In this manuscript, the authors describe their experience with the treatment of 8 high risk patients with pure, severe aortic valve regurgitation, using the self-expandable Acurate TA prosthesis through a transapical approach.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
August 18, 2014
August 18, 2014
In a two-part review, Bax and many other authorities on transcatheter aortic valve implantation (TAVI) provide an extensive overview of the open issues related to patient selection, treatment strategy, and procedural aspects that will help further improve outcomes after TAVI.
August 13, 2014
This video offers a step-by-step description of how to perform an aortic valve replacement, and was specifically created for cardiothoracic residents and fellows.
August 6, 2014
Bicuspid aortic valve (BAV) stenosis has been regarded as a relative contraindication for transcatheter aortic valve implantation (TAVI).
August 4, 2014
This video demonstrates a minimally invasive repair of a bicuspid aortic valve and ascending aortic aneurysm through the upper ministernotomy approach.
July 14, 2014
The timing of surgery in patients with asymptomatic severe aortic stenosis (AS) remains a matter of debate. In this study, the authors evaluate the prognostic value of plasma levels of B-type natriuretic peptide (BNP) during exercise in 211 patients with asymptomatic AS.
July 9, 2014
The objective of this study was to investigate whether the consequences of patient prosthesis mismatch (PPM) following aortic valve replacement (AVR) differ according to patient age.
July 8, 2014
The consortium of authors of this paper determined the survival after Transcatheter valve in valve implantation inside a failed surgical bioprosthesis. The authors report a 1 month mortality rate of 7.6% and a major stroke rate of 1.7%. One-year survival was 83.2%, and 313 (92.6%) of survivors had a good functional status (NYHA I/II).
July 4, 2014
The PARTNER trial reported reduced mortality in pts with prior CABG who underwent surgical AVR compared to TAVR. This study further explores the 288 pts in these two groups. The groups were similar in their clinical presentation and had similar instances of procedure-related mortality, stroke, and MI. The TAVR pts had more paravalvular leak, at 2